Invention Grant
- Patent Title: Heterocyclylamines as PI3K inhibitors
-
Application No.: US16446098Application Date: 2019-06-19
-
Publication No.: US10646492B2Publication Date: 2020-05-12
- Inventor: Yun-Long Li , Wenqing Yao , Andrew P. Combs , Song Mei , Joseph Glenn , Thomas P. Maduskuie, Jr. , Richard B. Sparks
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee: Incyte Corporation,Incyte Holdings Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; C07D471/04 ; C07D487/04 ; A61P29/00 ; C07D519/00
Abstract:
The present invention provides heterocyclylamine derivatives of Formula I: wherein the variables are defined herein, that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
Public/Granted literature
- US20190298724A1 HETEROCYCLYLAMINES AS PI3K INHIBITORS Public/Granted day:2019-10-03
Information query
IPC分类:
